Finance

Lists
Why is 532041 down 5,00%?
Dive Deeper
532041:BOM
Hindustan Bio Sciences Ltd
â‚đ7,22
-5,00%
(-0,38) 1D
13 āš•.āšĨ., 15 āŧ‚āšĄāš‡ 30 āš™āšēāš—āšĩ 00 āš§āšīāš™āšēāš—āšĩ GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532041...
Open
â‚đ7,70
High
â‚đ7,70
Low
â‚đ7,22
Mkt. cap
74,01 āšĨāŧ‰āšēāš™
Avg. vol.
11,71Â āšžāšąāš™
Volume
12,97Â āšžāšąāš™
52-wk high
â‚đ9,92
52-wk low
â‚đ5,00
EPS
â‚đ-0,19
No. of employees
5
Open
â‚đ7,70
High
â‚đ7,70
Low
â‚đ7,22
Mkt. cap
74,01 āšĨāŧ‰āšēāš™
Avg. vol.
11,71Â āšžāšąāš™
Volume
12,97Â āšžāšąāš™
52-wk high
â‚đ9,92
52-wk low
â‚đ5,00
EPS
â‚đ-0,19
No. of employees
5
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
46 āš™āšēāš—āšĩāšāŧˆāš­āš™
EverQuote (NASDAQ:EVER) Director Sells 1,593 Shares of Stock
Investor's Business Daily
Investor's Business Daily
·
3 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Dow Jones Futures: Stock Market Holds Up As Meta, AMD Lead Buys; ASML, CPI Inflation Due
About Hindustan Bio Sciences Ltd
CEO-
Employees5
Founded1991
Headquarters-
SectorBiotechnology
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
86,00Â āšžāšąāš™
4,00 āšĨāŧ‰āšēāš™
-68,00Â āšžāšąāš™
-
Cost of goods sold
-
2,37 āšĨāŧ‰āšēāš™
38,00Â āšžāšąāš™
-
Cost of revenue
-
2,37 āšĨāŧ‰āšēāš™
38,00Â āšžāšąāš™
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
496,00Â āšžāšąāš™
497,00Â āšžāšąāš™
571,00Â āšžāšąāš™
573,00Â āšžāšąāš™
Operating expense
670,00Â āšžāšąāš™
808,00Â āšžāšąāš™
1,52 āšĨāŧ‰āšēāš™
1,13 āšĨāŧ‰āšēāš™
Total operating expenses
670,00Â āšžāšąāš™
3,18 āšĨāŧ‰āšēāš™
1,56 āšĨāŧ‰āšēāš™
1,13 āšĨāŧ‰āšēāš™
Operating income
-584,00Â āšžāšąāš™
824,00Â āšžāšąāš™
-1,63 āšĨāŧ‰āšēāš™
-1,13 āšĨāŧ‰āšēāš™
Other non operating income
-
1,00Â āšžāšąāš™
-10,00Â āšžāšąāš™
-
EBT including unusual items
-585,00Â āšžāšąāš™
820,00Â āšžāšąāš™
-1,17 āšĨāŧ‰āšēāš™
-1,13 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-585,00Â āšžāšąāš™
820,00Â āšžāšąāš™
-1,63 āšĨāŧ‰āšēāš™
-1,13 āšĨāŧ‰āšēāš™
Income tax expense
-
-
-3,00Â āšžāšąāš™
-
Effective tax rate
-
-
0,26%
-
Other operating expenses
135,00Â āšžāšąāš™
192,00Â āšžāšąāš™
909,00Â āšžāšąāš™
556,00Â āšžāšąāš™
Net income
-585,00Â āšžāšąāš™
820,00Â āšžāšąāš™
-1,16 āšĨāŧ‰āšēāš™
-1,13 āšĨāŧ‰āšēāš™
Net profit margin
-680,23%
20,48%
1.710,29%
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
11,00Â āšžāšąāš™
-
Interest expense
-1,00Â āšžāšąāš™
-5,00Â āšžāšąāš™
-
-
Net interest expenses
-1,00Â āšžāšąāš™
-5,00Â āšžāšąāš™
11,00Â āšžāšąāš™
-
Depreciation and amortization charges
39,00Â āšžāšąāš™
119,00Â āšžāšąāš™
42,00Â āšžāšąāš™
-
EBITDA
-564,50Â āšžāšąāš™
824,50Â āšžāšąāš™
-1,58 āšĨāŧ‰āšēāš™
-1,08 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google